Sign in
Enrolling by invitationNo phase

Personalizing Treatment Delivery

Key facts

Who runs it
Rutgers, The State University of New Jersey
Where
Piscataway, United StatesSee the site
Trial code
Status
Enrolling by invitation
People taking part
81 people, planned
Started
21 Oct 2024
Expected to end
1 Jul 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Personalized intervention condition: Cognitive behavioral therapy skills
  • Therapeutic control condition: Cognitive behavioral therapy skills
  • Tracking control condition: Supportive counseling
Record updated
30 July 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Access to a smart phone
  • Between 18 and 65 years
  • Clinically significant anxiety or trauma-related symptoms
  • Alcohol use problems
  • Interest in telehealth counseling
  • Anticipated New Jersey or New York residence for the duration of the study

Who cannot take part

  • Currently receiving individual counseling or counseling at a higher level of care
  • Psychiatric medication that is not currently at a stable dose (or is not anticipated to remain at a stable dose for the duration of the study)
  • Demonstrated indicators of more intensive or acute care
  • Temporary residence within the state of New Jersey or New York or out-of-state residence from the state of New Jersey or New York

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Rutgers - Robert Wood Johnson Medical SchoolPiscataway, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Anxiety and anxiety-related disorders frequently co-occur with alcohol use problems resulting in an enormous humanitarian and economic cost to society. The proposed research will use digital technology to examine person-specific risk factors predicting problematic alcohol use in individuals vulnerable to anxiety and anxiety-related disorders and will use this information to design a personalized intervention for individuals seeking psychological treatment. Results from this research will integrate output from novel and innovative digital technology methods into psychotherapy, advancing research on personalized treatment and prevention efforts.

The 3 groups in the trial

  • Personalized intervention conditionTreatment being tested

    This experimental condition will test a data-driven, person-specific intervention using CBT skills.

    Treatment: Personalized intervention condition: Cognitive behavioral therapy skills

  • Therapeutic control conditionExisting treatment, for comparison

    This control condition will provide an experimental comparison to test the process of personalization.

    Treatment: Therapeutic control condition: Cognitive behavioral therapy skills

  • Tracking control conditionExisting treatment, for comparison

    This second control condition will provide an experimental comparison to test the effects of health-related tracking and therapeutic contact.

    Treatment: Tracking control condition: Supportive counseling

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Digital Phenotyping of Anxiety and Anxiety-Related Alcohol Comorbidity and Treatment
Criteria questions
Built from NCT05821634, who can take part
Record updated
30 July 2026